Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMFORT Toddlers
NL-OMON59638Phase 3Active, not recruiting
- Sponsor
- DBV Technologies
- Start
- Dec 2025
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of DBV712 Viaskin® in peanut allergy, sponsored by DBV Technologies. Started Dec 2025; status: active, not recruiting.
02
Drugs
DBV712 Viaskin®
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NL-OMON59638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59638.